Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
Higher proportion of participants achieved HbA1c levels below 6.5 percent with canagliflozin versus placebo
Larazotide May Speed Recovery in Children With Multisystem Inflammatory Syndrome
Faster resolution of GI symptoms, faster clearance of spike antigen, faster return to usual activities reported for children treated with larazotide
FDA Approves Vizz Eye Drops to Improve Near Vision in Adults
Trials show once-daily drops are safe and effective
Current Medical Use of Rx Stimulants for ADHD Up in Teens From 2005 to...
However, nonmedical use decreased over time
U.K. Begins Major Research Effort Into Trans Youth Health
Elevated INR in Older Adults on Warfarin May Not Be Tied to Risk for...
Authors say findings warrant re-examining approach to managing anticoagulation in older adults
Study Estimates COVID-19 Vaccinations Prevented More Than 2.5 Million Deaths in 2020 to 2024
Most life-years saved were among people aged 60 years or older; estimates are more conservative than those that focused on the first year of vaccination
FDA Requiring Stronger Safety Labels for Opioid Medications
Updated opioid safety labeling is based on new data from two large postmarketing observational studies
Rituximab Not Superior to Conventional Strategy for Eosinophilic Granulomatosis With Polyangiitis
Rituximab no better than glucocorticoids alone for inducing remission in patients with eosinophilic granulomatosis with polyangiitis
FDA Approves Empaveli for Rare Kidney Diseases
Approval is first treatment for C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis
